Document Type
Article
Publication Date
April 2022
Patent Number
11306059
CPC
C07D 211/90, C07C 233/88
Abstract
Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders. Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.
Application Number
16/758991
Recommended Citation
Weeber, Edwin John; Li, Qingyou; Peters, Melinda Marie; and Soueidan, Hana Marie, "Drug-induced activation of the Reelin signaling system" (2022). USF Patents. 1291.
https://digitalcommons.usf.edu/usf_patents/1291
Assignees
University of South Florida
Filing Date
10/25/2018